Malarone for malaria

Provided by: Healthwise
50% of users found this article helpful.

Examples

Brand Name Chemical Name
Malarone atovaquone and proguanil HCL

How It Works

Malarone is a combination medication that stops the development of parasites in the blood that cause malaria.

To prevent malaria, adults need to take one tablet daily 1 to 2 days before entering an area where malaria is present, continue taking it daily throughout their stay, and then take it for 7 days after they return.

To treat malaria, adults can take a single daily dose of four tablets for 3 days in a row.

Dosages for children vary depending on body weight.

Why It Is Used

People take Malarone to prevent and treat uncomplicated malaria that is caused by Plasmodium (P). falciparum. Doctors also use Malarone to treat people with malaria in areas that have chloroquine-resistant or other resistant strains.

How Well It Works

Malarone appears to be effective in the prevention and treatment of malaria caused by P. falciparum, including infections acquired in areas with chloroquine-resistant strains.1

Side Effects

Side effects in adults taking Malarone to prevent malaria include:

  • Headache.
  • Belly pain.
  • Canker sores (mouth ulcers).

Side effects in adults taking Malarone to treat malaria include:

  • Belly pain.
  • Nausea.
  • Vomiting.
  • Headache.

See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)

What To Think About

Malarone may effectively prevent and treat malaria in international travelers, but it may not work as well for people who live in areas where malaria is present.2

You should not take Malarone if you have some types of kidney disease.

Complete the new medication information form (PDF)Click here to view a form.(What is a PDF document?) to help you understand this medication.

References

Citations

  1. Centers for Disease Control and Prevention (2004). Treatment of malaria (Guidelines for clinicians). Available online: http://www.cdc.gov/malaria/pdf/clinicalguidance.pdf.

  2. Hogh B, et al. (2000). Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: A randomised, double-blind study. Lancet, 356(9245): 1888–1894.

Credits

Author Maria G. Essig, MS, ELS
Editor Susan Van Houten, RN, BSN, MBA
Associate Editor Denele Ivins
Associate Editor Pat Truman
Primary Medical Reviewer Martin Gabica, MD
- Family Medicine
Specialist Medical Reviewer W. David Colby IV, MSc, MD, FRCPC
- Infectious Disease
Last Updated May 16, 2007
Last Updated: 05/16/2007

© 1995-2007, Healthwise, Incorporated, P.O. Box 1989, Boise, ID 83701. ALL RIGHTS RESERVED.

This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information. For more information, click here. Privacy Policy. How this information was developed.

Was this article helpful?
Tell us what you think.

Rate this article:
liked it no thanks

Filter By:

In the Spotlight

Dealing With An Emergency

Do you know proper first aid techniques? Different emergency situations require different plans of action.

Learn more »

Yahoo! Groups

Join the Conversation:

Join a Yahoo! Group and discuss topics with other members of the group.

Start a Health Support Group »

Tell us what you think about Yahoo! Health - Send us your feedback